Chemoinformaics analysis of 3,5-dimethyl-1-dimethylphenylsilyloxybenzene
| Molecular Weight | 256.421 | nRot | 3 |
| Heavy Atom Molecular Weight | 236.261 | nRig | 12 |
| Exact Molecular Weight | 256.128 | nRing | 2 |
| Solubility: LogS | -6.357 | nHRing | 0 |
| Solubility: LogP | 5.36 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 12 |
| nHA | 1 | APOL | 46.3879 |
| nHD | 0 | BPOL | 37.2401 |
| QED | 0.759 |
| Synth | 2.317 |
| Natural Product Likeliness | -0.302 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.054 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.52 |
| MDCK | 0.0000121 |
| BBB | 0.033 |
| PPB | 0.993587 |
| VDSS | 1.519 |
| FU | 0.0119845 |
| CYP1A2-inh | 0.926 |
| CYP1A2-sub | 0.936 |
| CYP2c19-inh | 0.799 |
| CYP2c19-sub | 0.906 |
| CYP2c9-inh | 0.601 |
| CYP2c9-sub | 0.86 |
| CYP2d6-inh | 0.049 |
| CYP2d6-sub | 0.857 |
| CYP3a4-inh | 0.476 |
| CYP3a4-sub | 0.625 |
| CL | 3.908 |
| T12 | 0.349 |
| hERG | 0.104 |
| Ames | 0.027 |
| ROA | 0.006 |
| SkinSen | 0.539 |
| Carcinogencity | 0.289 |
| EI | 0.994 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.637545 |